Top Suppliers:I want be here


2207-75-2

2207-75-2 structure
2207-75-2 structure
  • Name: Potassium oxonate
  • Chemical Name: potassium,4,6-dioxo-1H-1,3,5-triazine-2-carboxylate
  • CAS Number: 2207-75-2
  • Molecular Formula: C4H2KN3O4
  • Molecular Weight: 195.175
  • Catalog: Organic raw materials Organometallic salt
  • Create Date: 2018-07-09 20:14:19
  • Modify Date: 2026-07-23 12:44:48
  • Oxonic acid potassium salt is an inhibitor of uricase, oxonic inhibits the phosphorylation of 5-FU to 5-fluorouridine-5'-monophosphate catalyzed by pyrimidine phosphoribosyl-transferase in a different manner from allopurinol in cell-free extracts and intact cells in vitro.IC50 value: Target: On p.o. administration of 5-FU (2 mg/kg) and a potent inhibitor of 5-FU degradation to Yoshida sarcoma-bearing rats, oxonic acid (10 mg/kg) was found to inhibit the formation of 5-fluorouridine-5'-monophosphate from 5-FU and its subsequent incorporation into the RNA fractions of small and large intestine but not of tumor and bone marrow tissues [1]. Oxonic acid diet increased plasma uric acid by 80-90 micromol/l, while blood pressure was elevated only in hyperuricemic 5/6 nephrectomy rats (18 mmHg) [2].

Name potassium,4,6-dioxo-1H-1,3,5-triazine-2-carboxylate
Synonyms OXONIC ACID POTASSIUM SALT
Oxonic acid potassium salt
1,3,5-Triazine-2-cboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-, potassium salt (1:1)
Potassium otastat
Potassium 4,6-Dihydroxy-1,3,5-triazine-2-carboxylate
Anti-NADPH oxidase 4
Allantoxanic Acid Potassium Salt Oxonic Acid Potassium Salt Potassium Allantoxanate Potassium 4,6-Dihydroxy-1,3,5-triazine-2-cboxylate
4,6-DIHYDROXY-1,3,5-TRIAZINE-2-CBOXYLIC ACID, POTASSIUM SALT
Hot selling Oteracil potassium
kox
Anti-NOX4 antibody produced in rabbit
Potassium 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylate
Anti-KOX-1
Potassium oxonate Oxonic acid potassium salt
oxonic acid potassium
Kidney oxidase-1 (KOX-1)
Potassium 4,6-dioxo-1H-1,3,5-triazine-2-cboxylate
Oxonic acid potassium salt (OXO)
Potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-cboxylate
POTASSIUMOXONATE/OTERACILPOTASSIUM
Allantoxanic acid potassium
1,4,5,6-Tetrahydro-4,6-dioxo-1,3,5-triazine-2-cboxylic acid potassium salt
PotassiumOxonate>
Potassium azaorotate
potassium 4,6-dioxo-1H-1,3,5-triazine-2-cboxylic acid
potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylate
Allantoxanic Acid Potassium Salt
LABOTEST-BB LT00138090
Kidney superoxide-producing NADPH oxidase
Anti-ZNF10, (N-terminal) antibody produced in rabbit
POTASSIUM 4,6-DIHYDROXY-1,3,5-TRIAZINE-2-CBOXYLATE
1,3,5-Triazine-2-carboxylic acid, 1,4,5,6-tetrahydro-4,6-dioxo-, potassium salt (1:1)
Allantoxanic acid
monopotassium 1,2,3,4-tetrahydro-2,4-dioxo-1,3,5-triazine-6-carboxylate
4,6-Dihydroxy-1,3,5-triazine-2-cboxylic acid potassium salt, Allantoxanic acid
Potassium 2,6-dihydroxytriazinecboxylate
Oxygen oxazine acid potassium
Oxonate
potassiumazaorotate
MFCD00010565
POTASSIUM ALLANTOXANATE
Potassium Oxoxazine Impurity
otassiuM oxonate
5-Aza-orotsaeure K-Salz
Potassium Oxonat
PotassiuM oxonate(OXO)
Oxonic acid,potassium salt
ALLANTOXANIC ACID POTASSIUM SALT
Anti-Kidney superoxide-producing NADPH oxidase
Oxonic acid potassium salt, Uricase inhibitor
(OXO)Oteracil potassium
POTASSIUM OXONATE
Oxonate,potassium
EINECS 218-627-5
KOX-1
Potassium Oxonate
Anti-Renal NAD(P)H-oxidase
Oxonic acid
Oteracil potassium(OXO)
Oxonic acid, potassium salt
Potassium s-triazine-2,4-dione-6-cboxylate
Potassium Allantoxanate
potassium 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-cboxylate
Oxonic acid potassium salt, >=
1,2,3,4-etetrahydro-2,4-dioxo-1,3,5-triazin-6-cboxylate
OTERACIL POTASSIUM
4,6-dioxo-1H-1,3,5-triazine-2-cboxylate
NOX4
Oteracil potassium
1,4,5,6-tetrahydro-4,6-dioxo-s-triazine-2-cboxylicacid,potassiumsalt
5-azaoroticacid,potassiumsalt
Description Oxonic acid potassium salt is an inhibitor of uricase, oxonic inhibits the phosphorylation of 5-FU to 5-fluorouridine-5'-monophosphate catalyzed by pyrimidine phosphoribosyl-transferase in a different manner from allopurinol in cell-free extracts and intact cells in vitro.IC50 value: Target: On p.o. administration of 5-FU (2 mg/kg) and a potent inhibitor of 5-FU degradation to Yoshida sarcoma-bearing rats, oxonic acid (10 mg/kg) was found to inhibit the formation of 5-fluorouridine-5'-monophosphate from 5-FU and its subsequent incorporation into the RNA fractions of small and large intestine but not of tumor and bone marrow tissues [1]. Oxonic acid diet increased plasma uric acid by 80-90 micromol/l, while blood pressure was elevated only in hyperuricemic 5/6 nephrectomy rats (18 mmHg) [2].
Related Catalog
References

[1]. Shirasaka T, et al. Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. Cancer Res. 1993 Sep 1;53(17):4004-9.

[2]. Eraranta A, et al. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency. J Hypertens. 2008 Aug;26(8):1661-8.

Melting Point 300 °C(lit.)
Molecular Formula C4H2KN3O4
Molecular Weight 195.175
Exact Mass 194.968231
PSA 118.74000
Storage condition Refrigerator, Under Inert Atmosphere

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RR4580000
CHEMICAL NAME :
Oxonic acid, potassium salt
CAS REGISTRY NUMBER :
2207-75-2
LAST UPDATED :
199704
DATA ITEMS CITED :
3
MOLECULAR FORMULA :
C4-H3-N3-O4.K
MOLECULAR WEIGHT :
196.20
WISWESSER LINE NOTATION :
T6MVMVNJ FVO &-KA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
3 gm/kg
SEX/DURATION :
female 8-9 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth) Reproductive - Specific Developmental Abnormalities - body wall
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,299,1976
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
4500 mg/kg
SEX/DURATION :
female 8-10 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - Central Nervous System
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,299,1976
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
10800 ug/kg
SEX/DURATION :
female 9-11 day(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - post-implantation mortality (e.g. dead and/or resorbed implants per total number of implants) Reproductive - Fertility - litter size (e.g. # fetuses per litter; measured before birth)
REFERENCE :
TXCYAC Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973- Volume(issue)/page/year: 6,289,1976
Hazard Codes Xn
Safety Phrases S24/25
WGK Germany 3
RTECS RR4580000
HS Code 2933699090
Precursor  1

DownStream  0

HS Code 2933699090
Summary 2933699090 other compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:20.0%
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.